Portfolio of Coronavirus Treatment and Vaccine Stocks

The following table includes 17 coronavirus treatment and vaccine stocks. For more information about these stocks see These 19 companies are working on coronavirus treatments or vaccines — here’s where things stand.

17 Coronavirus Treatment and Vaccine Stocks
Name & Monthly Returns	Symbol & Snapshot	Recent Prices & Trendline
AstraZeneca	AZN
BioNTech	BNTX
CytoDyn	CYDY
Emergent BioSolutions	EBS
Gilead Sciences	GILD
Inovio Pharmaceuticals	INO
Johnson & Johnson	JNJ
Mesoblast Limited	MESO
Moderna	MRNA
Novavax	NVAX
Pfizer	PFE
Regeneron Pharmaceuticals	REGN
Roche Holding	RHHBY
Sanofi	SNY
Takeda Pharmaceutical Company Ltd.	TAK
Translate Bio	TBIO
Vir Biotechnology	VIR
Sparkline weekly price charts based on Alpha Vantage data.

Portfolio Values

To inspect the performance of the Coronavirus Treatment and Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 12 stocks included in the portfolio computations are: AZN, CYDY, EBS, GILD, INO, JNJ, NVAX, PFE, REGN, RHHBY, SNY and TAK. The current value of the portfolio assumes that $833.33 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 5 stocks excluded from the portfolio computations because of insufficient price data are: BNTX, MESO, MRNA, TBIO and VIR.

The current value of the $10,000 investment is $11,949. The percent return is 19.49%. The annualized return is 3.63%.

Portfolio Value Chart for Last 100 Daily Closes

See Portfolio of Coronavirus Stocks.

See Portfolio of Coronavirus Lockdown Stocks.

See Portfolio of Coronavirus Vaccine Stocks.